Biktarvy, formally known as bictegravir sulfate, represents a potent single-tablet therapy for treating HIV infection. This formula combines three essential antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the HIV's ability to copy within the body, significantly decreasing the viral load. For many i